At Moffitt Cancer Center, we understand that many BMT CI patients face unexpected physical, emotional, psychological and social challenges as they transition from active treatment to survivorship.
Who we are: We are part of your provider team from within the BMT-CI program at Moffitt Cancer Center. You may have met us at some point during your treatment journey. As part of the BMT-CI Survivorship clinic, we will work closely with your primary transplant and cellular immunotherapy physician, advanced practice providers (APPs), and nurses to coordinate your care and help you succeed.
What we do: We meet with you at certain points during your recovery and get to know your individual medical history and needs. We then tailor specific recommendations to help guide your medical monitoring and treatment throughout your life.
Why survivorship?: The treatments you received can lead to many side effects. Some of these side effects may take years to develop. Transplant or cellular immunotherapy and the therapies leading up to it can increase your risk for other cancers or chronic illnesses. Our survivorship program will work together with you and your primary medical team to develop a personalized care plan for long-term monitoring and health care.
We focus on enhancing the overall quality of life for BMT-CI survivors. This may involve managing symptoms, optimizing nutrition and addressing other factors impacting well-being.
Regular check-ups and screenings can help in the early detection of late effects or complications related to the transplant or cellular immunotherapy. Early intervention can improve outcomes.
BMT-CI survivors may have an increased risk of developing secondary cancers. We make recommendations for long-term monitoring and screening, allowing for early detection and management.
In follow-up visits, we will review your care plan to accommodate changes in your health status, preferences or treatment options.
Madelyn Adams, RN, BSN
Madelyn is a Post-Cellular Therapy Coordinator, supporting patients through transplant and the transition to long-term follow-up care. She is excited to create resources that help patients and staff feel confident throughout the transition to life after transplant.
Leo Malpica, APRN
Leo enjoys meeting with patients to discuss their long-term goals and working collaboratively to create an individualized care plan that guides their healthcare journey after treatment.
Ella Vieira, NP
Ella has expertise in allo/auto transplant, CAR-T, TIL and TCR therapies for hematologic and solid tumors.
Daniel Gaylor, Social Work
Daniel is a Licensed Clinical Social Worker, a Board-Certified Oncology Social Worker, and an Advanced Certified Hospice and Palliative Care Social Worker. He serves as the Social Work Supervisor for BMT-CI and Malignant Hematology.
Mark J. DeNinno, BSN, RN, TCTCN
Mark has been a nurse in the BMT-CI Program for many years. He currently serves as the Clinic Operations Manager for the BMT-CI Outpatient Program, which includes the BMT-CI Clinic and Treatment Center, the BMT-CI Long-Term Follow-Up Clinic and Survivorship Clinics, and the BMT-CI Clinic Blood Draw.
Dr. Bejanyan is a Program Leader in BMT-CI and head of the Leukemia/Myeloid Section, specializing in AML, MDS and cellular immunotherapies.
Dr. Faramand specializes in cellular therapy and transplantation for acute leukemias and myelodysplastic syndromes.
Dr. Liu is the Medical Director of the BMT-CI Survivorship Program, also specializing in transplant and CAR T-cell therapy for multiple myeloma.
Dr. Nishihori is the Medical Director of the BMT program and is an expert in hematopoietic cell transplantation and cellular immunotherapy.
